Agents and Actions

, Volume 30, Issue 1–2, pp 67–69 | Cite as

Histamine secretion from mast cells stimulated with bradykinin

  • P. Y. Lee
  • F. L. Pearce
Histamine Release


Bradykinin and a range of peptide analogues induced a dose-dependent release of histamine from rat peritoneal mast cells. The characteristics of the release were not consistent with the involvement of defined bradykinin receptors but indicated that the peptide acted through the putative mast cell polyamine receptor. Consistently, the effect of bradykinin was largely confined to serosal mast cells of the rat and hamster, while human histaminocytes were essentially unresponsive. These data do then not support a general role for kinin-induced activation of mast cells in human allergic disease.


Peptide Mast Cell Histamine Bradykinin Allergic Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    D. Proud, A. Togias, R. Naclerio, S. A. Crush, P. S. Norman and L. M. Lichtenstein,Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J. clin. Invest.72, 1678–1685 (1983).PubMedGoogle Scholar
  2. [2]
    S. C. Christiansen, D. Proud and G. C. Cochrane,Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J. clin. Invest.79, 188–197 (1987).PubMedGoogle Scholar
  3. [3]
    R. W. Fuller, C. M. S. Dixon, F. M. C. Cuss and P. J. Barnes,Bradykinin-induced bronchoconstriction in humans. Am. Rev. respir. Dis.135, 176–180 (1986).Google Scholar
  4. [4]
    A.R. Johnson and E.G. Erdos,Release of histamine from mast cells by vasoactive peptides. Proc. Soc. exp. Biol. Med.142, 1252–1256 (1973).PubMedGoogle Scholar
  5. [5]
    H. Ali and F. L. Pearce,Isolation and properties of cardiac and other mast cells from the rat and guinea pig. Agents and Actions16, 138–140 (1985).PubMedGoogle Scholar
  6. [6]
    N. Rhaleb, S. Dion, P. D'Orleans-Juste, G. Drapeau, D. Regali and R. G. Browne,Bradykinin antagonism: differentiation between peptide antagonists and anti-inflammatory agents, Eur. J. Pharmacol.151, 275–279 (1988).PubMedGoogle Scholar
  7. [7]
    G. W. Read, S. M. Hong and E. F. Kiefer,Competitive inhibition of 48/80-induced histamine release by benzalkonium chloride and its analogs and the polyamine receptor in mast cells. J. Pharmac. exp. Ther.222, 652–657 (1982).Google Scholar
  8. [8]
    F. L. Pearce, T. A. Kassessinoff and W. L., Liu,Characteristics of histamine secretion induced by neuropeptides: implications for the relevance of peptide-mast cell interactions in allergy and inflammation. Int. Arch. Allergy appl. Immunol.88, 129–131 (1989).PubMedGoogle Scholar
  9. [9]
    I. D. Lawrence, J. A. Warner, V. L. Cohan, L. M. Lichtenstein, A. Kagey-Sobotka, R. J. Vavrek, J. M. Stewart and D. Proud,Induction of histamine release from human skin mast cells by bradykinin analogs. Biochem. Pharmacol.38, 227–233 (1989).PubMedGoogle Scholar
  10. [10]
    D. Proud, D. W. MacGlashan, H. H. Newball, A. Schulmans and L. M. Lichtenstein,Immunoglobin E-mediated release of a kininogenase from purified human lung mast cells. Am. Rev. respir. Dis.132, 405–406 (1985).PubMedGoogle Scholar
  11. [11]
    M. Maier, J. Spragg and L. B. Schwartz,Inactivation of high molecular weight kininogenase by human lung mast cell tryptase. J. Immunol.130, 2352–2358 (1983).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1990

Authors and Affiliations

  • P. Y. Lee
    • 1
  • F. L. Pearce
    • 1
  1. 1.The Department of ChemistryUniversity College LondonLondonUK

Personalised recommendations